z-logo
open-access-imgOpen Access
Letter to the editor: pharmacokinetics of gemcitabine in non-small-cell lung cancer patients: impact of the 79A>C cytidine deaminase polymorphism
Author(s) -
Cédric Mercier,
Laétitia Dahan,
L’Houcine Ouafik,
Nicolás André,
Joseph Ciccolini
Publication year - 2010
Publication title -
european journal of clinical pharmacology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.845
H-Index - 108
eISSN - 1432-1041
pISSN - 0031-6970
DOI - 10.1007/s00228-010-0859-5
Subject(s) - cytidine deaminase , gemcitabine , medicine , lung cancer , university hospital , clinical oncology , oncology , cancer , immunology , antibody
International audienc

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom